We are pleased to announce that Company has received the approval from the General Directorate of Medicines, Supplies and Drugs (DIGEMID), PERU for its Generic, Injectable & OSD (Unit -1 in Amritsar) and For Oncology, Injectable & OSD (Unit-3 in Himachal Pradesh)
Upcoming audits at Kwality Pharmaceuticals in Q2 2024 includes INVIMA (Colombia), DIGEMID (Peru) and SFDA (Saudi Arabia)
Kwality Pharmaceutical manufacturing facilities are recently inspected by Botswana Medicines Regulatory Authority (BoMRA) from 11-16’th April 2024
Kwality Pharmaceutical Manufacturing Facility in Himachal Pradesh has been approved by ANVISA
Kwality develops it’s First Implant Injection : Goserelin Acetate Implant Injection
FOR ORDERS
FOR QUERY
FOR JOBS